1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone
C81H81N15O3S3 — CID 157068011
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone
1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone (PubChem CID 157068011) has the molecular formula C81H81N15O3S3 and a molecular weight of 1408.84 g/mol. Its IUPAC name is 1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone.
Molecular Properties
| Compound Name | 1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone |
|---|---|
| PubChem CID | 157068011 |
| Molecular Formula | C81H81N15O3S3 |
| Molecular Weight | 1408.84 g/mol |
| Exact Mass | 1407.58 |
| IUPAC Name | 1-[3-methyl-4-(1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl)phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4R)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone;1-[3-methyl-4-[(4S)-1-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[5,4-e][1,4]thiazepin-4-yl]phenyl]-2-(2-methyl-3-pyridinyl)ethanone |
| SMILES | Cc1cc(C(=O)Cc2cccnc2C)ccc1C1SCCNc2c1c(-c1ccccn1)nn2C.Cc1cc(C(=O)Cc2cccnc2C)ccc1[C@@H]1SCCNc2c1c(-c1ccccn1)nn2C.Cc1cc(C(=O)Cc2cccnc2C)ccc1[C@H]1SCCNc2c1c(-c1ccccn1)nn2C |
| InChI | InChI=1S/3C27H27N5OS/c3*1-17-15-20(23(33)16-19-7-6-12-28-18(19)2)9-10-21(17)26-24-25(22-8-4-5-11-29-22)31-32(3)27(24)30-13-14-34-26/h3*4-12,15,26,30H,13-14,16H2,1-3H3/t2*26-;/m10./s1 |
| InChIKey | ACCIEKDAHIILKT-BRLFTNGRSA-N |
| XLogP | 15.50 |
| TPSA | 218.10 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 102 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1408.84 |
| LogP ≤ 5 | 15.50 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157068011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.